Success cases
Strategic Evaluation of miRNAs to Treat Cachexia
Scientific and market validation to advance miRNA-based cachexia therapies
Challenge
Arvor’s objective was to prioritize and validate the miRNAs with the highest therapeutic potential in cachexia, within a strategy based on antisense RNA. The aim was to identify viable targets and assess their fit in a clinical and commercial setting still lacking specific solutions.
Solution
An in-depth analysis of the scientific and clinical landscape of cachexia was conducted, identifying the most promising miRNAs. Molecular mechanisms, preclinical evidence, and market opportunities were evaluated to define a differential and viable therapeutic strategy.
Result
Two key miRNAs were identified with strong supporting evidence and no direct competition in active trials. The study consolidated an innovative strategy to address cachexia and positioned the technology with a clear competitive advantage.
“The study consolidated an innovative strategy to address cachexia”
Success case studies in the sector Biotech
success stories Market analysis